Showing results (1-10 of 143) with videos related to
Sort By:
Pageof 15
Basic & Clinical Pharmacology & Toxicology|July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic modelDaniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.The New Zealand Medical Journal|August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is neededStephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.Journal of Diabetes and Metabolic Disorders|March 29, 2019
The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitusMarion Muller, Benjamin J Wheeler, Miranda Blackwell, et al.The Journal of Pharmacy and Pharmacology|January 6, 2015
Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasmaHesham S Al-Sallami, Natalie J MedlicottClinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B DuffullJournal of Pharmacokinetics and Pharmacodynamics|March 2, 2021
Reduction of quantitative systems pharmacology models using artificial neural networksAbdallah Derbalah, Hesham S Al-Sallami, Stephen B DuffullClinical Pharmacokinetics|January 14, 2018
A Review of the Methods and Associated Mathematical Models Used in the Measurement of Fat-Free MassJaydeep Sinha, Stephen B Duffull, Hesham S Al-SallamiClinical Pharmacokinetics|April 29, 2018
Choosing the Allometric Exponent in Covariate Model BuildingJaydeep Sinha, Hesham S Al-Sallami, Stephen B DuffullClinical Pharmacokinetics|October 5, 2019
Evaluating the Relationship Between Lean Liver Volume and Fat-Free MassJaydeep Sinha, Stephen B Duffull, Bruce Green, et al.Current Drug Metabolism|May 16, 2020
Evaluating Lean Liver Volume as a Potential Scaler for In Vitro-In Vivo Extrapolation of Drug Clearance in Obesity Using the Model Drug AntipyrineJaydeep Sinha, Stephen B Duffull, Bruce Green, et al.Pageof 15